Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

News! Some have early access? Hehehe

$Windtree Therapeutics (WINT.US)$ Reuters· just
Windtree Completes Enrollment of Phase 2B Study of Istaroxime in Early Cardiogenic Shock
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
5
Translate
Report
5970 Views
Comment
Sign in to post a comment